BioHelix’s IsoAmp® HSV Assay received FDA clearance for the detection of herpes simplex virus in genital and oral lesions - October 17, 2011
OPKO Health Announces Acquisition of Claros Diagnostics securing the unique microfluidics-based diagnostic technology platform. A great success for SCP clients Claros Diagnostics and Oxford Bioscience Partners that provides an even greater upside for OPKO Health. - October 13, 2011
SCP Consultant Geoff McKinley has joined GenturaDx as SVP R&D - July 11, 2011
Connecticut Innovations is set to gain on the proposed $101 million sale of Ipsogen S.A. to Qiagen N.A. which was announced on June 15, 2011. Connecticut Innovations contracted SCP for its Ipsogen investment due diligence.
IVDT - Danaher acquiring Beckman Coulter - March 2011
“A Troponin test recall, integration problems after the acquisition of Olympus, and the very late to market development of the DxN molecular diagnostics test system, which has been projected for a 2012 launch, are all indications that this once best-in-class company needed a change,” said Manfred Scholz, PhD, president, Scholz Consulting Partners LLC (Medford, MA). “At $3.7 billion in annual sales, Beckman Coulter was too small to compete with Abbott Laboratories, Roche Diagnostics, and Siemens Healthcare Diagnostics, and too large to nimbly compete with molecular diagnostics growth businesses like Qiagen and Cepheid.”
IVDT - More M&As in IVD industry - October 2010